Cassava Sciences
SAVA
#9287
Rank
A$0.15 B
Marketcap
A$3.30
Share price
12.26%
Change (1 day)
32.19%
Change (1 year)

Earnings for Cassava Sciences (SAVA)

Earnings in 2025 (TTM): -A$0.18 Billion

According to Cassava Sciences 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -A$0.2 Billion a decrease over its 2023 earnings that were of -A$0.15 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cassava Sciences from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$0.18 Billion-11.3%
2024 -A$0.2 Billion34.28%
2023 -A$0.15 Billion32.41%
2022 -A$0.12 Billion143.46%
2021 -A$45.6 Million383.92%
2020 -A$9.43 Million36.96%
2019 -A$6.88 Million-25.56%
2018 -A$9.25 Million-44.25%
2017 -A$16.58 Million-20.11%
2016 -A$20.75 Million5.32%
2015 -A$19.71 Million14.23%
2014 -A$17.25 Million-139.64%
2013 A$43.51 M
2010 -A$19.01 Million102.87%
2009 -A$9.37 Million-177.52%
2008 A$12.08 M-14.32%
2007 A$14.1 M-1942.21%
2006 -A$0.77 Million
2004 -A$54.06 Million75.1%
2003 -A$30.87 Million
2001 -A$24.03 Million20.49%
2000 -A$19.94 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-A$0.2 Billion 27.50%๐Ÿ‡บ๐Ÿ‡ธ USA